EP3254695
SAMSETT MEÐFERÐ MEÐ MÓTEFNUM GEGN CLAUDIN 18.2 Í MEÐFERÐ VIÐ KRABBAMEINI
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
21.5.2013EP published:
9.9.2020EP application number:
17171169.0
EP translation filed:
23.11.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
20.5.2033Expiry date:
20.5.2025
Title:
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
Timeline
Today
21.5.2013EP application
9.9.2020EP Publication
23.11.2020Translation submitted
15.12.2020Registration published
20.5.2025Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbHAddress:
Freiligrathstrasse 12, 55131 Mainz, DE
Inventor
Name:
SAHIN, UgurAddress:
55116 Mainz, DE
Name:
TÜRECI, ÖzlemAddress:
55116 Mainz, DE
Name:
MITNACHT-KRAUS, RitaAddress:
61169 Friedberg, DE
Name:
JACOBS, Stefan, DenisAddress:
55252 Mainz-Kastel, DE
Name:
UTSCH, Magdalena, JadwigaAddress:
55262 Heidesheim am Rhein, DE
Name:
HEINZ, Cornelia, Adriana, MariaAddress:
55278 Dalheim, DE
Name:
STADLER, Christiane, ReginaAddress:
64625 Bensheim, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2012/002210Date:
23.5.2012Country:
WO
Classification
Categories:
A61K 39/395, C07K 16/30, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 3.5.2021
Expires: 20.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 3.5.2022
Expires: 20.5.2023
Payer: Patice ehf.
Number: 11
Paid: 23.5.2023
Expires: 20.5.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 2.5.2024
Expires: 20.5.2025
Payer: Árnason Faktor ehf.